Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD)
Charlotte Suppli Ulrik
Department of Clinical Medicine
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Glycopyrrolate
100%
Chronic Obstructive Pulmonary Disease
57%
Bronchodilator Agents
21%
Cholinergic Agents
17%
Tiotropium Bromide
13%
Exercise Tolerance
11%
Therapeutics
10%
Expert Testimony
9%
Dyspnea
8%
Health Status
8%
Pharmacology
6%